Trademarkia Logo

Australia

AU$
ACTIMAB
Removed - Not renewed: Renewal fee not paid

Last updated on 4 Apr 2023

Owner Info

Actinium Pharmaceuticals, Inc. incorporated in the State of Delaware

501 Fifth Avenue, 3rd Floor, New York,

New York, 10017,, UNITED STATES OF AMERICA

Serial Number

1517742 filed on 28 Sept 2012

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

ACTIMAB

Classification Information


Class [005]
Pharmaceutical and veterinary preparations; pharmaceutical products for the prevention and treatment of cancer

Mark Details


Serial Number

1517742

Registered On

28 Sept 2012

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Apr 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
4th Apr 2023IP Right Ceased correspondence sent
4th Apr 2023Status change to Removed/Ceased - Not Renewed
3rd Oct 2022Renewal Overdue correspondence sent
28th Jul 2022Renewal Reminder correspondence sent
30th May 2013IP Right Registration Published
22nd May 2013Register Trade Mark
22nd May 2013Application Status
14th May 2013Registration fee (1 class)
14th Feb 2013IP Right Acceptance Published
8th Feb 2013Clear Examination report approved